Diakine-DK12 7 (EGFR)

N/A

Report date: 2023/03/07 16:09:39

Base Information

Drug NameDiakine-DK12 7 (EGFR)
Drug Alias NameDiakine™- DK12 7 (EGFR)Diakine™- DK127 (EGFR)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionAnti-Epidermal growth factor receptor erbB1Interleukin-12 stimulantsInterleukin-7 receptors stimulants
TargetsEpidermal growth factor receptor erbB1Interleukin-12Interleukin-7 receptors
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDeka Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesDeka Biosciences Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A